298 related articles for article (PubMed ID: 17983394)
1. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
Morales-Vásquez F; Gonzalez-Angulo AM; Broglio K; Lopez-Basave HN; Gallardo D; Hortobagyi GN; De La Garza JG
Breast J; 2007; 13(6):551-6. PubMed ID: 17983394
[TBL] [Abstract][Full Text] [Related]
2. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the treatment and prognosis of recurrent breast phyllodes tumor].
Fang Y; Gao JD; Tian YT; Xie YQ; Zhen S
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):72-4. PubMed ID: 19538877
[TBL] [Abstract][Full Text] [Related]
4. Phyllodes tumors of the breast: a review of 32 cases.
Geisler DP; Boyle MJ; Malnar KF; McGee JM; Nolen MC; Fortner SM; Broughan TA
Am Surg; 2000 Apr; 66(4):360-6. PubMed ID: 10776873
[TBL] [Abstract][Full Text] [Related]
5. Management of phyllodes breast tumors.
Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
[TBL] [Abstract][Full Text] [Related]
6. Phyllodes tumor of the breast.
Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes--treatment results.
Soumarová R; Seneklová Z; Horová H; Vojkovská H; Horová I; Budíková M; Růzicková J; Jezková B
Arch Gynecol Obstet; 2004 May; 269(4):278-81. PubMed ID: 15205980
[TBL] [Abstract][Full Text] [Related]
9. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies.
Chia SK; Speers CH; Bryce CJ; Hayes MM; Olivotto IA
J Clin Oncol; 2004 May; 22(9):1630-7. PubMed ID: 15117985
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
[TBL] [Abstract][Full Text] [Related]
12. Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.
Tokuda Y; Tajima T; Narabayashi M; Takeyama K; Watanabe T; Fukutomi T; Chou T; Sano M; Igarashi T; Sasaki Y; Ogura M; Miura S; Okamoto S; Ogita M; Kasai M; Kobayashi T; Fukuda H; Takashima S; Tobinai K; ;
Cancer Sci; 2008 Jan; 99(1):145-51. PubMed ID: 17970786
[TBL] [Abstract][Full Text] [Related]
13. [The effectiveness of adjuvant chemotherapy with anthracyclines (adriablastin, doxorubicin) for stage-IIb-IIIa breast cancer].
Semiglazov BF; Bozhok AA; Ivanova OA; Ivanov VG; Barash NIu; Orlov AA; Golubeva OM; Seleznev IK; Migmanova NSh; Popova RT
Vopr Onkol; 1998; 44(4):403-7. PubMed ID: 9807202
[TBL] [Abstract][Full Text] [Related]
14. [Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie].
Haberer S; Laé M; Seegers V; Pierga JY; Salmon R; Kirova YM; Dendale R; Campana F; Reyal F; Miranda O; Fourquet A; Bollet MA
Cancer Radiother; 2009 Jul; 13(4):305-12. PubMed ID: 19524472
[TBL] [Abstract][Full Text] [Related]
15. Malignant phyllodes tumor of the breast: local control rates with surgery alone.
Pezner RD; Schultheiss TE; Paz IB
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):710-3. PubMed ID: 18234448
[TBL] [Abstract][Full Text] [Related]
16. The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer.
Clouth B; Chandrasekharan S; Inwang R; Smith S; Davidson N; Sauven P
Eur J Surg Oncol; 2007 Oct; 33(8):961-6. PubMed ID: 17215100
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13-year experience.
Kok KY; Telesinghe PU; Yapp SK
J R Coll Surg Edinb; 2001 Aug; 46(4):198-201. PubMed ID: 11523709
[TBL] [Abstract][Full Text] [Related]
18. Phyllodes tumors of the breast: a case series of 106 patients.
Ben Hassouna J; Damak T; Gamoudi A; Chargui R; Khomsi F; Mahjoub S; Slimene M; Ben Dhiab T; Hechiche M; Boussen H; Rahal K
Am J Surg; 2006 Aug; 192(2):141-7. PubMed ID: 16860620
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy for phyllodes tumor of breast.
Chaney AW; Pollack A; McNeese MD; Zagars GK
Radiat Oncol Investig; 1998; 6(6):264-7. PubMed ID: 9885942
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy.
Yonemori K; Katsumata N; Kaneko M; Uno H; Matsumoto K; Kouno T; Shimizu C; Ando M; Takeuchi M; Fujiwara Y
Breast Cancer Res Treat; 2007 Jul; 103(3):313-8. PubMed ID: 17063267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
